NANECH

ST:NANECH Sweden Biotechnology
Market Cap
$651.58K
Skr7.31 Million SEK
Market Cap Rank
#37481 Global
#613 in Sweden
Share Price
Skr0.02
Change (1 day)
-18.37%
52-Week Range
Skr0.02 - Skr0.10
All Time High
Skr0.10
About

NanoEcho AB (publ) engages in developing diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden.

NANECH (NANECH) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: -0.179x

Based on the latest financial reports, NANECH (NANECH) has a cash flow conversion efficiency ratio of -0.179x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.64 Million) by net assets (Skr14.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NANECH - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how NANECH's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

NANECH Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NANECH ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for NANECH (2022–2025)

The table below shows the annual cash flow conversion efficiency of NANECH from 2022 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr14.73 Million Skr-16.16 Million -1.097x -38.81%
2024-12-31 Skr18.47 Million Skr-14.60 Million -0.790x -5.34%
2023-12-31 Skr18.50 Million Skr-13.88 Million -0.750x +45.81%
2022-12-31 Skr11.50 Million Skr-15.92 Million -1.385x --